Comparison between ibuterol hydrochloride and terbutaline in asthma.

Abstract

The bronchodilating effect, circulatory effects, and subjective side effects of ibuterol hydrochloride, the di-isobutyric acid ester of terbutaline, at two dose levels (2 and 4 mg) were compared with those of 5 mg terbutaline sulphate in a double-blind cross-over study on 12 patients with asthma. Both drugs were given by mouth. The 2-mg dose of ibuterol had the same bronchodilating effect during the first three hours as 5 mg terbutaline. The 4-mg dose, however, produced a significantly greater increase in the peak expiratory flow rate between the 30th and 120th minutes than terbutaline. No significant changes in heart rate or pulse amplitude were noted, and there was no difference in the incidence of subjective side effects between ibuterol at either dose level and terbutaline.

• Authors: B Arner, P O Magnusson
• Journal: British medical journal (Br Med J) Vol. 1 Issue 6001 Pg. 72-4 (Jan 10 1976) ISSN: 0007-1447 [Print] England
• PMID: 1106810 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)

Chemical References

• Butyrates
• ibuterol
• Terbutaline

Topics

• Asthma (drug therapy)
• Blood Pressure (drug effects)
• Bronchi (drug effects)
• Butyrates (pharmacology, therapeutic use)
• Clinical Trials as Topic
• Dose-Response Relationship, Drug
• Heart Rate (drug effects)
• Humans
• Pulse (drug effects)
• Terbutaline (analogs & derivatives, pharmacology, therapeutic use)
• Time Factors